Author:
Cheung Yue Yat Harrison,Lau Eric Ho Yin,Yin Guosheng,Lin Yun,Cowling Benjamin J.,Lam Kwok Fai
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference35 articles.
1. Artificial intelligence in COVID-19 drug repurposing.;Zhou;Lancet Digit Health,2020
2. US Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults. 2021 [cited 2022 Nov 2]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain
3. Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2-A narrative review.;Masyeni;J Med Virol,2022
4. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.;Khoo;Lancet Infect Dis,2023
5. Molnupiravir: is it time to move in or move out?;Castillo Almeida;NEJM Evid.,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献